Medications for Alzheimer
Although present medications will not therapy Alzheimer’s or stop it from progressing, they may help reduce symptoms, such as recollection loss and disarray, for a limited time.
The U.S. Food and pharmaceutical Administration (FDA) has accepted two kinds of medications — cholinesterase inhibitors (Aricept, Exelon, Razadyne, Cognex) and memantine (Namenda) — to treat the cognitive symptoms (memory decrease, confusion, and problems with conceiving and reasoning) of Alzheimer's infection.
As Alzheimer’s progresses, brain units die and attachments among units are lost, initating cognitive symptoms to worsen. While present medications will not halt the damage Alzheimer’s causes to mind units, they may help lessen or stabilize symptoms for a limited time by affecting certain chemicals involved in carrying notes amidst the brain's cheek cells. Doctors occasionally prescribe both types of medications simultaneously. Some medical practitioners also prescribe high doses of vitamin E for cognitive alterations of Alzheimer's infection.
Medications for early to moderate phases
All of the prescription medications currently accepted to treat Alzheimer’s symptoms in early to moderate phases are from a class of pharmaceuticals called cholinesterase inhibitors. Cholinesterase inhibitors are prescribed to treat symptoms related to memory, thinking, dialect, judgment and other considered methods.
Before beginning a new medication, make sure your physician and pharmacist are cognizant of all medications actually being taken (including over-the-counter and alternate preparations). This is important to make certain medications will not interact with one another, initating side consequences.
Prevent the breakdown of acetylcholine (a-SEA-til-KOH-lean), a chemical messenger significant for learning and memory. This supports connection amidst nerve units by keeping acetylcholine grades high.
hold up worsening of symptoms for 6 to 12 months, on mean, for about half the people who take them.
Are generally well endured. If edge effects occur, they routinely encompass nausea, vomiting, loss of appetite and advanced frequency of bowel movements.
Three cholinesterase inhibitors are commonly prescribed:
Donepezil (Aricept) is accepted to heal all stages of Alzheimer's.
Rivastigmine (Exelon) is accepted to treat gentle to moderate Alzheimer's.
Galantamine (Razadyne) is accepted to heal gentle to moderate Alzheimer's.
Tacrine (Cognex) was the first cholinesterase inhibitor accepted. medical practitioners rarely prescribe it today because it's affiliated with more grave side consequences than the other three pharmaceuticals in this class.